Table 2.
Kidney function in the study participants.
| All study participants, (N) | (3554) | |
| Chronic kidney disease*, % (N) | 21.5 (764) | |
| Creatinine (mg/dL), mean, (SD) | 0.98 (0.35) | |
| eGFR (mL/min · 1.73 m2), mean, (SD) | 75.6 (18.3) | |
| Patients with eGFR > 90 mL/min · 1.73 m2, % (N) | 24.1 (858) | |
| Patients with eGFR 60–90 mL/min · 1.73 m2, % (N) | 56.1 (1933) | |
| Patients with eGFR 45–60 mL/min · 1.73 m2, % (N) | 12.3 (436) | |
| Patients with eGFR 30–45 mL/min · 1.73 m2, % (N) | 5.9 (211) | |
| Patients with eGFR 15–30 mL/min · 1.73 m2, % (N) | 1.2 (43) | |
| Patients with eGFR < 15 mL/min · 1.73 m2, % (N) | 0.3 (11) | |
Abbreviations: eGFR, estimated glomerular filtration rate.
*Chronic kidney disease was defined as the presence of kidney damage or an estimated glomerular filtration rate (eGFR) lower than 60 ml/min/1.73 m2, persisting for three months or more.